Logo

BCSCDB: Biomarkers of Cancer Stem Cells Database

Number of entries related to SW48 cell line is 130

GENE HGNC_ID MARKER_TYPE CANCER_TYPE HISTOLOGICAL_TYPE CELL_LINE CSC_ENRICHMENT METHOD EXPRESSION_LEVEL CONFIDENCE_SCORING GLOBAL_SCORING PUBMED_ID
DPP43009LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs and Western Blotting followed by IF staining and SFANA0.640.008531285270
EPCAM11529LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs and Western Blotting followed by IF staining and SFANA0.640.21131285270
EPCAM11529LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFA and qRT-PCRNA0.640.21129693155
EPCAM11529LTMDukes Type B Colon CancerAdenocarcinomaSW480NAIHC stainingNA0.640.21131810923
EPCAM11529LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs and SFANA0.640.21124970802
EPCAM11529LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.640.21121454414
EPCAM11529LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA and FACsNA0.640.21125804133
LGR54504LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs and Western Blotting followed by IF staining and SFANA0.640.075331285270
LGR54504LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFA and qRT-PCRNA0.640.075329307822
LGR54504LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by SFA and Western BlottingNA0.640.075328560069
LGR54504LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs for CSC marker followed by qRT-PCRNA0.640.075333744851
LGR54504LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA and RT-PCRNA0.640.075328464221
LGR54504LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by Tumorigenicity assay and RT-PCRNA0.640.075321435460
ABCB140LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by qRT-PCR and Western BlottingNA0.480.060424926880
ABCG274LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by qRT-PCR and Western BlottingNA0.480.173924450541
ABCG274LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFA and qRT-PCRNA0.480.173929693155
ABCG274LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.480.173928212529
ABCG274LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.480.173929805588
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by qRT-PCR and Western BlottingNA0.48124926880
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by Western BlottingNA0.48131139149
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by IF staining and SFANA0.48131285270
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFA and IF stainingNA0.48129693155
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by Western BlottingNA0.48126785732
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAWestern BlottingNA0.48122319203
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAIHC stainingNA0.48131810923
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs for CSC marker followed by qRT-PCRNA0.48133744851
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.48132617772
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.48125154976
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.48125154976
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.48127520449
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.48131505062
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.48132729895
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs and SFANA0.48124970802
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.48121454414
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.48122329848
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.48129805588
CD441681LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA and MACsNA0.48124696849
NANOG20857LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by qRT-PCR and Western BlottingNA0.480.546124926880
NANOG20857LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by Western BlottingNA0.480.546130774996
NANOG20857LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by SFA and Western BlottingNA0.480.546128560069
NANOG20857LTMDukes Type B Colon CancerAdenocarcinomaSW480NAqRT-PCRNA0.480.546129426374
NANOG20857LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by qPCRNA0.480.546131349708
NANOG20857LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by qRT-PCRNA0.480.546129307822
POU5F19221LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by qRT-PCR and Western BlottingNA0.480.644824926880
POU5F19221LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by Western BlottingNA0.480.644830774996
POU5F19221LTMDukes Type B Colon CancerAdenocarcinomaSW480NAWestern Blotting followed by SFANA0.480.644830802541
POU5F19221LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by qRT-PCRNA0.480.644835267511
POU5F19221LTMDukes Type B Colon CancerAdenocarcinomaSW480NAqRT-PCRNA0.480.644829426374
POU5F19221LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by qRT-PCRNA0.480.644829307822
POU5F19221LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by Tumorigenicity assay and RT-PCRNA0.480.644821435460
POU5F19221LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.480.644828212529
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by qRT-PCR and Western BlottingNA0.480.758224926880
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFA and Western BlottingNA0.480.758234798428
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by Western BlottingNA0.480.758222319203
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by Western BlottingNA0.480.758231139149
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFA and qRT-PCRNA0.480.758229307822
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NART-PCR followed by FACsNA0.480.758229899829
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.480.758232617772
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.480.758233744851
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.480.758234815662
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.480.758224122993
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.480.758230429213
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs and SFANA0.480.758221694723
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.480.758221454414
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.480.758228212529
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.480.758229805588
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.480.758231285270
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFA and Tumorigenicity assayNA0.480.758222074823
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA and FACsNA0.480.758225804133
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by MACsNA0.480.758230941956
PROM19454LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by FACsNA0.480.758221720213
SOX211195LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by qRT-PCR and Western BlottingNA0.480.569524926880
SOX211195LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFA and qRT-PCRNA0.480.569529693155
SOX211195LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by Western BlottingNA0.480.569530774996
SOX211195LTMDukes Type B Colon CancerAdenocarcinomaSW480NAWestern Blotting followed by SFANA0.480.569530802541
SOX211195LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by qRT-PCRNA0.480.569535267511
SOX211195LTMDukes Type B Colon CancerAdenocarcinomaSW480NAqRT-PCRNA0.480.569529426374
SOX211195LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by qPCRNA0.480.569531349708
SOX211195LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by qRT-PCRNA0.480.569529307822
SOX211195LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by Tumorigenicity assay and RT-PCRNA0.480.569521435460
DCLK12700LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by Western BlottingNA0.40.015922319203
DCLK12700LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by Western BlottingNA0.40.015926785732
DCLK12700LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by Western BlottingNA0.40.015930144515
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NAALDEFLUOR assay followed by SFA and RT-PCRNA0.320.68428464221
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFA and qRT-PCRNA0.320.68429693155
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by qPCR and ALDEFLUOR assayNA0.320.68431349708
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by RT-PCR and ALDEFLUOR assayNA0.320.68430774996
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by Western BlottingNA0.320.68426785732
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by Western BlottingNA0.320.68430144515
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NAALDEFLUOR assay followed by FACs and SFANA0.320.68421694723
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NAIHC stainingNA0.320.68431810923
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs for CSC marker followed by qRT-PCRNA0.320.68433744851
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NAALDEFLUOR assayNA0.320.68419923910
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NAALDEFLUOR assayNA0.320.68424122993
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NAALDEFLUOR assay followed by SFANA0.320.68427927191
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NAALDEFLUOR assay followed by SFANA0.320.68429805588
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NAALDEFLUOR assay followed by SFANA0.320.68430410666
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NAALDEFLUOR assay followed by SFA and Tumorigenicity assayNA0.320.68422074823
ALDH1A1402LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by ALDEFLUOR assay and Tumorigenicity assayNA0.320.68421720213
MIR312038295LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFA and qRT-PCRNA0.320.001129307822
CTNNB12514LTMDukes Type C Colon CancerAdenocarcinomaSW48DoxorubicinWestern BlottingNA0.280.064727517620
CTNNB12514LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by SFA and Western BlottingNA0.280.064728560069
CTNNB12514LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by qPCRNA0.280.064731349708
HMGA15010LTMDukes Type B Colon CancerAdenocarcinomaSW480NAWestern BlottingNA0.280.004224833610
KLF46348LTMDukes Type C Colon CancerAdenocarcinomaSW48DoxorubicinWestern BlottingNA0.280.089127517620
MYC7553LTMDukes Type C Colon CancerAdenocarcinomaSW48DoxorubicinWestern BlottingNA0.280.130427517620
POU5F19221LTMDukes Type C Colon CancerAdenocarcinomaSW48DoxorubicinWestern BlottingNA0.280.644827517620
POU5F19221LTMDukes Type C Colon CancerAdenocarcinomaSW48NAWestern Blotting followed by SFANA0.280.644830802541
SCD10571LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA followed by Western BlottingNA0.280.012733430034
SOX211195LTMDukes Type C Colon CancerAdenocarcinomaSW48NAWestern Blotting followed by SFANA0.280.569530802541
SOX911204LTMDukes Type B Colon CancerAdenocarcinomaSW480NAWestern BlottingNA0.280.024422319203
TGFB111766LTMDukes Type C Colon CancerAdenocarcinomaSW48DoxorubicinWestern BlottingNA0.280.013827517620
MIR302C31764HTM/LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs for CSC marker followed by qRT-PCRDown0.20.002132617772
ALCAM400LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA and RT-PCRNA0.20.058328464221
ALCAM400LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA and FACsNA0.20.058325804133
CD241645LTMDukes Type C Colon CancerAdenocarcinomaSW48RegorafenibqRT-PCRNA0.20.45635197754
CD441681LTMDukes Type C Colon CancerAdenocarcinomaSW48RegorafenibqRT-PCRNA0.2135197754
CD441681LTMDukes Type C Colon CancerAdenocarcinomaSW48DoxorubicinFACsNA0.2127517620
DNAJB823699LTMDukes Type B Colon CancerAdenocarcinomaSW480NASP assay followed by RT-PCRNA0.20.002124145190
MIR12731509LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs for CSC marker followed by qRT-PCRNA0.20.004233744851
PROM19454LTMDukes Type C Colon CancerAdenocarcinomaSW48RegorafenibqRT-PCRNA0.20.758235197754
PROM19454LTMDukes Type C Colon CancerAdenocarcinomaSW48DoxorubicinFACsNA0.20.758227517620
CD241645LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.120.45627520449
CD241645LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.120.45631505062
CD241645LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.120.45629805588
CD241645LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFA and Tumorigenicity assayNA0.120.45622329848
CD241645LTMDukes Type B Colon CancerAdenocarcinomaSW480NASFA and MACsNA0.120.45624696849
CD241645LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACsNA0.120.45630429213
ITGA66142LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.120.026529805588
ITGB16153LTMDukes Type B Colon CancerAdenocarcinomaSW480NAFACs followed by SFANA0.120.01822329848